It's How Medicine Should Be®

Translate

French German Italian Portuguese Russian

SCENT Trial

Clinical Trial Title: 
SCENT trial: Surpass intracranial aneurysm embolization system pivotal study to treat large or giant wide neck aneurysms
Clinical Trial Protocol ID: 
12103001
Clinical Trial Investigator Name: 
Demetrius Lopes, MD
Clinical Trial Protocol Description: 

A multi-center, prospective, non-randomized trial to evaluate the safety and effectiveness of the Surpass Flow Diverter compared to a historical control in the treatment of large or giant wide neck intracranial aneurysms.
 

Clinical Trial Eligibility Criteria: 

In order to participate you must meet the following criteria:

  • Are 19 to 80 years old.
  • Have a single targeted intracranial aneurysm that:
    • Is located in the internal carotid artery (ICA) distribution up to the terminus.
    • Has a neck >4 mm or no discernible neck and an aneurysm size >10 mm (including saccular, fusiform and dissecting configuration).

This is a partial list of elgibility requirements. To inquire about your eligibility, please call the contact number provided. 

Clinical Trial Area: 
Stroke and Cerebrovascular Disease
Contact Phone: 
(312) 942-1114
Contact Name: 
Bartosz Jacher